miR-185 inhibits cell migration and invasion of hepatocellular carcinoma through CDC42.

miR-185 inhibits cell migration and invasion of hepatocellular carcinoma through CDC42.
复制标题

DOI:
10.3892/ol.2018.8971
复制
发表时间:
2018-09
期刊:
影响因子:
2.9
通讯作者:
Liu K
Liu K
中科院分区:
医学4区
文献类型:
--
作者:
Zhang Q;Chen Y;Liu K

文献摘要

参考文献

被引文献

相似文献

肝细胞癌(HCC)是一种发病率高、死亡率高的原发性肝癌。miR-185是一种大约有22-28个核苷酸的microRNA,据报道与许多癌症有关。研究了miR-185通过细胞分裂周期42 (CDC42)作用于HCC的潜在机制。RT-qPCR检测HCC组织和细胞中miR-185和CDC42的RNA水平。采用双荧光素酶报告基因试验验证CDC42是否是miR-185的靶基因。Transwell法检测迁移和侵袭对miR-185的影响。miR-185在HCC中的表达较低,且与CDC42呈负相关。miR-185抑制HCC的迁移、侵袭,miR-185低表达预示预后不良。CDC42被预测为miR-185的靶基因,并受miR-185调控。miR-185通过CDC42抑制细胞在HCC中的迁移和侵袭能力。综上所述,miR-185通过直接靶向CDC42抑制HCC细胞的迁移和侵袭。这表明miR-185/CDC42轴可能是HCC治疗的新靶点。
Hepatocellular carcinoma (HCC) is a primary liver cancer with high incidence and mortality. miR-185, a microRNA with appriximately 22-28 nucleotides, was reported to be involved in many cancers. The potential mechanism of miR-185 on HCC through cell division cycle 42 (CDC42) was investigated. RT-qPCR was used to measure the RNA level of miR-185 and CDC42 in HCC tissues and cells. The dual luciferase reporter assay was used to verify whether CDC42 was a target gene for miR-185. Transwell assay was employed to detect the ability of migration and invasion to change miR-185. miR-185 expression was low in HCC and negatively correlated with CDC42. miR-185 inhibited HCC migration, invasion and miR-185 low expression predicted poor prognosis. CDC42 was predicted to be a target gene for miR-185, and regulated by miR-185. miR-185 suspressed the ability of cell migration and invasion through CDC42 in HCC. In conclusion, miR-185 suspressed migration and invasion of HCC cells by directly targeting CDC42. It is suggested that miR-185/CDC42 axis may present a novel target for HCC treatment.
DOI: 10.1038/nature03702
发表时间: 2005-06-09
期刊: NATURE
影响因子: 64.8
作者:
Lu, J;Getz, G;Golub, TR
通讯作者: Golub, TR
Onco-miR-130 通过靶向 TGF beta R2 促进胃癌细胞增殖和迁移
DOI: 10.18632/oncotarget.9936
发表时间: 2016-07-12
期刊: Oncotarget
影响因子: --
作者:
Duan J;Zhang H;Qu Y;Deng T;Huang D;Liu R;Zhang L;Bai M;Zhou L;Ying G;Ba Y
通讯作者: Ba Y
DOI: 10.1016/j.imbio.2009.06.014
发表时间: 2009-09-01
期刊: IMMUNOBIOLOGY
影响因子: 2.8
作者:
Porta, Chiara;Larghi, Paola;Sica, Antonio
通讯作者: Sica, Antonio
MicroRNA-185 下调 LNCaP 前列腺癌细胞系中雄激素受体的表达
DOI: 10.3892/mmr.2015.3332
发表时间: 2015-06-01
影响因子: 3.4
作者:
Liu, Chunyan;Chen, Zhaobo;Jiang, Anli
通讯作者: Jiang, Anli
DOI: 10.1517/14728222.2013.828037
发表时间: 2013-11
影响因子: 5.8
作者:
Arias-Romero LE;Chernoff J
通讯作者: Chernoff J